[{"indications": "Indications\u00a0\n(From Dabigatran etexilate: British National Formulary)\nDabigatran etexilate", "name": "DABIGATRAN ETEXILATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.8 Anticoagulants and protamine", "2.8.2 Oral anticoagulants", "Dabigatran etexilate"], "cautions": "Cautions\u00a0\n(From Dabigatran etexilate: British National Formulary)\nDabigatran etexilate; also elderly; body-weight less than 50\u00a0kg; recent surgery; anaesthesia with postoperative\r\nindwelling epidural catheter (risk of paralysis\u2014give initial dose\r\nat least 2 hours after catheter removal and monitor neurological signs); bacterial endocarditis (increased risk of bleeding); bleeding disorders; active\r\ngastro-intestinal ulceration; assess renal function\r\nbefore treatment in all patients and at least annually in elderly\r\nand patients with renal impairment; concomitant use of\r\ndrugs that increase risk of bleeding; interactions: Appendix 1 (dabigatran etexilate)", "side-effects": "Side-effects\u00a0nausea, dyspepsia, diarrhoea, abdominal pain,\r\nanaemia, haemorrhage\u2014\n(From Dabigatran etexilate: British National Formulary)\nDabigatran etexilate; less commonly hepatobiliary disorders, vomiting, dysphagia,\r\ngastro-intestinal ulcer, gastro-oesophageal reflux, oesophagitis,\r\nthrombocytopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/201055.htm", "doses": ["Prophylaxis of venous thromboembolism following total\r\nknee replacement surgery, adult over\r\n18 years, 110\u00a0mg (elderly over 75 years,\r\n75\u00a0mg) 1\u20134 hours after surgery, then 220\u00a0mg (elderly over 75 years or patient receiving concomitant\r\ntreatment with amiodarone or verapamil, 150\u00a0mg) once daily for 9 days", "Prophylaxis of venous thromboembolism following total hip replacement\r\nsurgery, adult over 18 years, 110\u00a0mg\r\n(elderly over 75 years, 75\u00a0mg) 1\u20134\r\nhours after surgery, then 220\u00a0mg (elderly over 75 years or patient receiving concomitant\r\ntreatment with amiodarone or verapamil, 150\u00a0mg) once daily for 27\u201334\r\ndays", "Prophylaxis of stroke and systemic embolism in non-valvular\r\natrial fibrillation (see notes above), adult over 18 years, 150\u00a0mg (elderly over 80 years, patients at high risk of bleeding, or receiving concomitant\r\ntreatment with verapamil, 110\u00a0mg) twice daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless essential\u2014toxicity\r\nin animal studies"}]